Skip to content
MedsAcross

Manufacturer

ViiV Healthcare

Pharmaceutical manufacturer based in United Kingdom
United Kingdom
Products listed
23
Molecules
12
Therapy areas
1

ViiV Healthcare is a pharmaceutical manufacturer based in United Kingdom. MedsAcross lists 23 of its products across 12 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
United Kingdom
Indian manufacturer
No
Also listed as
ViiV Healthcare B.V., ViiV Healthcare BV, ViiV Healthcare Company
EU marketing authorisation holder
YesSource: European Medicines Agency
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply ViiV Healthcare products through licensed channels, with the documents your regulator needs.

HIV

22 presentations

HIV overview
MedicineActive ingredientRegisterAvailability
Apretude kit Cold chainCabotegravirUS FDAAvailable on request
Combivir 150 mg/300 mg tabletOralLamivudine and ZidovudineUS FDAAvailable on request
Dovato 50 mg/300 mg tabletOralDolutegravir and LamivudineUS FDAAvailable on request
Epivir 10 mg/mL oral solutionOralLamivudineUS FDAAvailable on request
Epivir 150 mg tabletOralLamivudineUS FDAAvailable on request
Epivir 300 mg tabletOralLamivudineUS FDAAvailable on request
Juluca 50 mg/25 mg tabletOralDolutegravir and RilpivirineUS FDAAvailable on request
Retrovir 10 mg/mL oral solutionOralZidovudineUS FDAAvailable on request
Retrovir 100 mg capsuleOralZidovudineUS FDAAvailable on request
Retrovir 200 mg/20 mL injectionIntravenousZidovudineUS FDAAvailable on request
Rukobia 600 mg extended-release tabletOralFostemsavirUS FDAAvailable on request
Selzentry kitMaravirocUS FDAAvailable on request
Selzentry 150 mg tabletOralMaravirocUS FDAAvailable on request
Selzentry 300 mg tabletOralMaravirocUS FDAAvailable on request
Tivicay 10 mg tabletOralDolutegravirUS FDAAvailable on request
Tivicay 25 mg tabletOralDolutegravirUS FDAAvailable on request
Tivicay 50 mg tabletOralDolutegravirUS FDAAvailable on request
Tivicay PD 5 mg tablet for oral suspensionOralDolutegravirUS FDAAvailable on request
Triumeq 600 mg/50 mg/300 mg tabletOralAbacavir, Dolutegravir and LamivudineUS FDAAvailable on request
Triumeq PD kitAbacavirUS FDAAvailable on request
Vocabria 30 mg tabletOralCabotegravirUS FDAAvailable on request
Ziagen 20 mg/mL oral solutionOral Cold chainAbacavirUS FDAAvailable on request

Other products

1 presentation

MedicineActive ingredientRegisterAvailability
Cabenuva kit Cold chainCabotegravir and RilpivirineUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from ViiV Healthcare

Send a request for any of these products. We confirm the licensed source, documents and lead time.